As the COVID-19 pandemic continues, we’ve added more human cells to our expanding list of products for COVID-19 research. Our new ACE2-GFP cell lines include smooth muscle, endothelial, and epithelial cells from organs that are most affected by the virus.
Studying how the coronavirus attacks these cells is crucial to understanding both the short-term and long-term effects of the virus. With these cells, researchers can better understand the underlying biology of the COVID-19 virus and its effects on the respiratory and pulmonary systems.
Read more to see the new cells.
| Name | Catalog # | Type | Species | Applications | Size | Price |
|---|---|---|---|---|---|---|
| ACE2-GFP Human Lung Airway Smooth Muscle Cells | HMC001 | Primary Cells | Cell Assays | 500,000 Cells | $1,294.80 | |
| ACE2-GFP Human Pulmonary Artery Endothelial Cells | HEC24 | Primary Cells | Human | Cell Assays | 500,000 Cells | $1,294.80 |
| ACE2-GFP Human Pulmonary Bronchial/Tracheal Epithelial Cells | HPEC003 | Primary Cells | Human | Cell Assays | 500,000 | $1,294.80 |
| ACE2-GFP Human Pulmonary Lobar Bronchial Epithelial Cells | HPEC001 | Primary Cells | Human | Cell Assays | 500,000 Cells | $1,294.80 |
| ACE2-GFP Human Pulmonary Small Airway Epithelial Cells | HPEC002 | Primary Cells | Human | Cell Assays | 500,000 Cells | $1,294.80 |
See all of our COVID-19 research products here.